OpenAlex
PricingAboutJobs
Log inGet started
Work

Reply: Beneficial effect of interleukin-2-based immunomodulation in Alzheimer-like pathology

HTML

Year: 2017
Type: letter
Source: Brain
DOI: 10.1093/brain/awx109
Authors: Sandro Alves, Guillaume Churlaud, David Klatzmann, Nathalie Cartier
Institutions: Université Paris-Sud, Inserm, Commissariat à l'Énergie Atomique et aux Énergies Alternatives, Université Paris-Saclay, CEA Paris-Saclay - Etablissement de Fontenay-aux-roses, Molecular Imaging Research Center, Sorbonne Université, Assistance Publique – Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Immunologie - Immunopathologie - Immunothérapie, Université Pierre-et-Marie-Curie
Language: English

Topic: Alzheimer's disease research and treatments
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Keywords: interleukin-2, Alzheimer's disease, immunomodulation, amyloid-beta, APP/PS1 mice, hippocampus, regulatory T cells, synaptic plasticity, memory impairment, amyloid plaques, Aβ42/Aβ40 ratio, neuroinflammation, treatment timing
SDG: Good health and well-being

Open Access status: closed

Funder: Agence Nationale de la Recherche
Awards: Sorbonne Universités à Paris pour l'Enseignement et la Recherche, Infrastructure de Recherche Translationnelle pour les Biothérapies en Neurosciences
OpenAlex ID: W2612835152
Cites: 14
Cited by: 33
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security